These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 839445)

  • 41. Contribution of rat pulmonary metabolism to the elimination of lidocaine, midazolam, and nifedipine.
    Aoki M; Okudaira K; Haga M; Nishigaki R; Hayashi M
    Drug Metab Dispos; 2010 Jul; 38(7):1183-8. PubMed ID: 20371639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
    Chow FS; Piekoszewski W; Jusko WJ
    Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data.
    Hayes KA; Brennan B; Chenery R; Houston JB
    Drug Metab Dispos; 1995 Mar; 23(3):349-53. PubMed ID: 7628300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetic studies on hepatic handling of glucagon using the model of non-recirculating perfused rat livers.
    Hildebrandt W; Blech W; Kohnert KD
    Horm Metab Res; 1991 Sep; 23(9):410-3. PubMed ID: 1743612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The physiologic basis for clearance measurements in hepatology.
    Winkler K; Bass L; Keiding S; Tygstrup N
    Scand J Gastroenterol; 1979; 14(4):439-48. PubMed ID: 482856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process.
    Hung DY; Chang P; Weiss M; Roberts MS
    J Pharmacol Exp Ther; 2001 May; 297(2):780-9. PubMed ID: 11303070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic clearance and drug metabolism using isolated perfused rat liver.
    Liu Y; Weber SJ; Onua ET
    Curr Protoc Pharmacol; 2004 Oct; Chapter 7():Unit 7.9. PubMed ID: 22294125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variation in hepatic extraction ratio with unbound drug fraction: discrimination between models of hepatic drug elimination.
    Byrne AJ; Morgan DJ; Harrison PM; McLean AJ
    J Pharm Sci; 1985 Feb; 74(2):205-7. PubMed ID: 3989694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First-pass effect and intrinsic clearance of propranolol and pindolol in the isolated perfused rat liver.
    Basset HM; Robins AH
    S Afr Med J; 1980 Dec; 58(24):971-3. PubMed ID: 7444700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
    Ahmad AB; Bennett PN; Rowland M
    J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of hepatic clearance with the account of drug-protein binding kinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct and indirect measurement of the hepatic extraction ratio of indocyanine green in the rat.
    Burns E; Ball CE; Christie JP; Broadhead GD; Tucker GT; Bax ND
    Clin Sci (Lond); 1989 May; 76(5):503-8. PubMed ID: 2721117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow.
    Reilly CS; Wood AJ; Koshakji RP; Wood M
    Anesthesiology; 1985 Jul; 63(1):70-6. PubMed ID: 4014773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
    Wang HJ; Benet LZ
    Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simplified isolated perfused rat liver apparatus: characterization and measurement of extraction ratios of selected compounds.
    Sinha V; Brendel K; Mayersohn M
    Life Sci; 2000 Mar; 66(19):1795-804. PubMed ID: 10809177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.
    Rowland M; Leitch D; Fleming G; Smith B
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):129-47. PubMed ID: 6491897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of marker drugs to measure organ function: a theoretical interpretation.
    Cobby J; Makoid MC
    Eur J Clin Pharmacol; 1980 Nov; 18(6):511-6. PubMed ID: 7461018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.